The head of the UN agency focusing on AIDS says he'll leave his post in June, an early departure announced a week after independent experts looking into sexual harassment at UNAIDS blasted its "defective leadership."
A BHIVA members' survey on U=U was undertaken in October 2018 which highlighted a need to ensure the U=U message is consistently integrated into clinical care, as recommended in the 2018 BHIVA standards of care for people living with HIV.
How one boy is tackling stereotypes in Kazakhstan.
HIV Outcomes launch an Online Compendium of Good Practices for securing the long-term health and well-being of people living with HIV. Although people with HIV can now anticipate near-normal life expectancy, there are unique needs that must be met if their quality of life is to match ...
MPP signs licence with AbbVie to expand access to key hepatitis C treatment, glecaprevir/pibrentasvir
The Medicines Patent Pool (MPP) has announced a new, royalty-free licence agreement with AbbVie for glecaprevir/pibrentasvir (G/P) – a World Health Organization (WHO)-recommended treatment for people living with chronic hepatitis C (HCV).
Peng Liyuan, wife of President Xi Jinping, expressed support on Monday for the Bill & Melinda Gates Foundation's efforts to strengthen cooperation with China, as well as third parties, in capacity building medical professionals for China and the world, when meeting with Bill Gates, the ...
A dual antiretroviral regimen containing dolutegravir (Tivicay) and boosted darunavir (Prezista) maintains viral suppression in most people who switch from a suppressive three-drug regimen, according to an observational study presented at the recent IDWeek in San Francisco. However, two drugs may not be enough for ...
Janssen Presents Positive Long-Term Efficacy and Safety of SYMTUZA® in Treatment-Naïve Adults with HIV-1
New Phase 3 AMBER study data continues to demonstrate high rates of virologic suppression at 96 weeks in ART-naïve adults with HIV-1 when treated with D/C/F/TAF.
The Advisory Board to the Emergency Support Fund for Key Populations in Eastern Europe and Central Asia (EECA) starts to function.
Improving long-term health and well-being of people living with HIV: Learning from country experiences in chronic care
Launch event hosted by Christofer Fjellner MEP (EPP, Sweden), Karin Kadenbach (S&D, Austria) and Frédérique Ries (ALDE, Belgium).
In 3 years of the #Partnership Program the state funding of HIV programs in EECA countries increased 15-fold
The ECUO summed up the results of the regional program “Partnership for Equal Access to HIV Services in Eastern Europe and Central Asia”.
Tuberculosis is soon to face a complete reboot: scientists are working on updating the diagnostics, treatment and vaccines. Yesterday, on October 24, the 49-th International Union Conference on Lung Health opened in The Hague (the Netherlands). The conference brought together 4,000 delegates from 80 countries, ...
EECA countries can achieve great results in fighting the HIV epidemic by optimizing costs. The new joint project uniting 15 countries of Eastern Europe and Central Asia is aimed at a more efficient redistribution of allocated funds.
Estonian Criminal Code does not contain an article specifically penalizing HIV transmission, but there are other ways to influence people's destinies at the constitutional level.
For successful advocacy in EECA countries, it is necessary to consolidate all key groups at the country level, as well as have access to city authorities. At the #Partnership Forum, representatives of organizations working with global donors discussed the implementation of common plans, shared successful ...
Tatiana Davletgaliyeva, GF Coordinator in Kazakhstan: the problem lies not in the government, but in the NGOs themselves (video)
Since 2009, the Republic of Kazakhstan has been providing free antiretroviral therapy to all PLWH entirely at the expense of the republican budget. The next stage is HIV prevention and implementation of a social contracting, carried out in coordination with NGOs.
For quality monitoring of medicines procurement and access to treatment, it is very important to pay attention to what is happening beyond the spreadsheets with figures.
Vladimir Mayanovskiy: EECA CAB will focus on developing a consolidated position about ART in the region
Monitoring of ARV prices will improve community advocacy interaction with government agencies, pharmaceutical companies and global donors.